Redx to resume RXC004 clinical trial programme
Clinical Research | News | 0 Comment | 22 Jan, 2019
UK based Biotechnology Company, Redx has announced that the UK’s Medicines and Healthcare products Regulatory Agen...Read more
Abcam, Loulou Foundation enters research collaboration for CDKL5 deficiency disorder
Clinical Research | News | 0 Comment | 22 Jan, 2019
Abcam, a global innovator in life science reagents and tools, and the Loulou Foundation, a private UK-based foundation d...Read more
TaiwanJ Pharma announces new clinical results on AIH drug
Clinical Research | News | 0 Comment | 22 Jan, 2019
TaiwanJ Pharmaceuticals, a specialty pharmaceutical company dedicated to the development and commercialization of small ...Read more
Lilly reports results of ANNOUNCE
Clinical Research | News | 0 Comment | 21 Jan, 2019
Eli Lilly and Company has reported that the results of ANNOUNCE, the Phase 3 study of LARTRUVO (olaratumab), in combinat...Read more
AIVITA gets IND nod for Phase 1B melanoma trial
Clinical Research | News | 0 Comment | 17 Jan, 2019
AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced that the U.S. Fo...Read more
United Neuroscience gets positive results from Ph2a trial for Alzheimer's vaccine
Clinical Research | News | 0 Comment | 17 Jan, 2019
United Neuroscience (UNS), a clinical-stage biotech company pioneering a new class of medicine to treat and prevent brai...Read more
Bridge Bio receives FDA ODD for IPF drug
Clinical Research | News | 0 Comment | 17 Jan, 2019
Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea and a tenant compan...Read more
Immunocore names David Berman as Head of R&D
Clinical Research | News | 0 Comment | 16 Jan, 2019
Clinical-Stage Biotechnology company, Immunocore has announced David Berman as its new Head of Research and Development....Read more
Innovent announces dosing of patient in a Ph1 clinical trial of Anti-CD47 MAb
Clinical Research | News | 0 Comment | 16 Jan, 2019
Innovent Biologics, a world-class biopharmaceutical company that develops and commercializes high quality medicines has ...Read more
NIH starts clinical trial for FMT
Clinical Research | News | 0 Comment | 15 Jan, 2019
A research consortium of NIH recently began enrolling patients in a clinical trial examining whether fecal microbiota tr...Read more
UroGen Pharma announces positive results of UGN-101
Clinical Research | News | 0 Comment | 14 Jan, 2019
A clinical stage pharma company, UroGen Pharma developing treatments to address unmet needs in the field of urology has ...Read more
CellMax, Medigen partner for cell therapy clinical trials
Clinical Research | News | 0 Comment | 11 Jan, 2019
CellMax Life, a US based diagnostics company with a proprietary technology to detect precancer and cancer cells in blood...Read more
Forbius announces the first patient dosed in a Phase 1 trial of AVID200
Clinical Research | News | 0 Comment | 09 Jan, 2019
Forbius, a clinical-stage company developing biologics for the treatment of cancer and fibrosis, announced that the firs...Read more
Immutep collaborates with CYTLIMIC
Clinical Research | News | 0 Comment | 08 Jan, 2019
Immutep Limited has announced that it has entered into a clinical trial collaboration agreement, a supply agreement and ...Read more
Solasia initiates Phase III programme for PledOx
Clinical Research | News | 0 Comment | 07 Jan, 2019
Solasia Pharma K.K. has announced the initiation of Phase III clinical trial for PledOx in Japan. In November 2017, Sol...Read more
USFDA approves Portola Pharmaceuticals’ Andexxa®
Clinical Research | News | 0 Comment | 03 Jan, 2019
Portola Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s ...Read more
Apellis Pharmaceuticals provides update on its Phase 3 program
Clinical Research | News | 0 Comment | 01 Jan, 2019
Apellis Pharmaceuticals Inc. has provided an update on the status of its Phase 3 program for APL-2 in patients with...Read more
Apellis Pharmaceuticals’ APL-2 receives orphan drug designation from the FDA
Clinical Research | News | 0 Comment | 01 Jan, 2019
Apellis Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on the development of novel therap...Read more